Dr. Mohammad Pashmforoush, MD

Dr. Pashmforoush practices at Tri-City Cardiology and Arrhythmia Services in Oceanside, California.

Dr. Pashmforoush's NPI, 1699722397, was assigned on May 28, 2006. Dr. Pashmforoush graduated from Pritzker School of Medicine in 1994. Dr. Pashmforoush holds California license A60730.

Dr. Pashmforoush's primary practice is Tri-City Cardiology and Arrhythmia Services, at 2424 Vista Way, Oceanside, CA 92054-6169. The practice phone is (760) 630-1606.

Dr. Pashmforoush's primary practice is Tri-City Cardiology and Arrhythmia Services in Oceanside, California. Dr. Pashmforoush is also affiliated with Sharp Tri-City Medical Center. Dmand AI also links Dr. Pashmforoush to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pashmforoush practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Pashmforoush's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Pashmforoush is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Pashmforoush is licensed in California.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chest pain, chronic hypertension and coronary artery disease among the conditions Dr. Pashmforoush treats.

CMS data shows 4,702 Medicare services from Dr. Pashmforoush across 40 procedure codes in 2024, for 763 Medicare patients. Medicare paid $387,154 for them.

CMS counts 763 Medicare patients who saw Dr. Pashmforoush in 2024. The largest group is 75 to 84, with 253 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pashmforoush's median patient age at 73, with 46% women.

In 2024, Dr. Pashmforoush wrote 4,278 Medicare Part D claims for 658 patients. 84% of them were for generic drugs. CMS names the drug for 3,975 of them, across 45 drugs with 11 or more claims each, at $680,705 in total drug cost. In 2023, CMS named 3,810 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Pashmforoush for performance year 2024, reported individually. Dr. Pashmforoush accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 72 procedures of pacemaker insertion or repair by Dr. Pashmforoush, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Pashmforoush. Dr. Pashmforoush's most frequent co-author is Markus Plate, MD.

CMS Open Payments shows 494 general payments to Dr. Pashmforoush from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Abbott Laboratories paid the most, $11,008.

Dr. Pashmforoush graduated from Pritzker School of Medicine in 1994.

Dr. Pashmforoush is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.